Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

Histopathology
C W Elston, I O Ellis

Abstract

Morphological assessment of the degree of differentiation has been shown in numerous studies to provide useful prognostic information in breast cancer, but until recently histological grading has not been accepted as a routine procedure, mainly because of perceived problems with reproducibility and consistency. In the Nottingham/Tenovus Primary Breast Cancer Study the most commonly used method, described by Bloom & Richardson, has been modified in order to make the criteria more objective. The revised technique involves semiquantitative evaluation of three morphological features--the percentage of tubule formation, the degree of nuclear pleomorphism and an accurate mitotic count using a defined field area. A numerical scoring system is used and the overall grade is derived from a summation of individual scores for the three variables: three grades of differentiation are used. Since 1973, over 2200 patients with primary operable breast cancer have been entered into a study of multiple prognostic factors. Histological grade, assessed in 1831 patients, shows a very strong correlation with prognosis; patients with grade I tumours have a significantly better survival than those with grade II and III tumours (P less than 0.0001). The...Continue Reading

Associated Clinical Trials

References

Oct 1, 1979·Journal of Clinical Pathology·B StenkvistO Eriksson
Mar 1, 1991·British Journal of Cancer·C LovekinR W Blamey
May 1, 1990·Journal of Clinical Pathology·S LewisI O Ellis
Jun 1, 1989·British Journal of Cancer·N BouzubarR I Nicholson
Jan 1, 1988·European Journal of Cancer & Clinical Oncology·R D Cardiff
Sep 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G ContessoJ Rouesse
Oct 1, 1987·British Journal of Cancer·J H ToddJ L Haybittle
Feb 1, 1987·The British Journal of Surgery·C S DowleR W Blamey
Oct 30, 1971·British Medical Journal·F Hartveit
Apr 1, 1972·British Journal of Cancer·H R ChampionR J Prescott
Jan 1, 1968·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A S Tavares
Sep 1, 1968·British Journal of Cancer·I M Hamlin
Jun 1, 1969·British Journal of Cancer·I C ToughJ Bruce
Mar 1, 1966·British Journal of Cancer·B Wolff
Jul 1, 1982·The American Journal of Surgical Pathology·R W McDivittD Gersell
Feb 1, 1984·The Australian and New Zealand Journal of Surgery·C W Elston
Mar 1, 1982·British Journal of Cancer·J L HaybittleK Griffiths
Mar 1, 1981·Human Pathology·D Ellis
Sep 1, 1950·British Journal of Cancer·H J G BLOOM
Dec 1, 1950·British Journal of Cancer·H J G BLOOM
Feb 1, 1921·Annals of Surgery·A C Broders

❮ Previous
Next ❯

Citations

Aug 19, 1999·The Journal of Pathology·E LeygueP H Watson
Feb 19, 1999·Cancer·M NadjiA R Morales
Oct 23, 1997·International Journal of Cancer. Journal International Du Cancer·I K BukholmA L Børresen-Dale
Nov 14, 1997·International Journal of Cancer. Journal International Du Cancer·M JiangJ A Fontana
Jan 8, 1998·International Journal of Cancer. Journal International Du Cancer·R SoongP D Robbins
Mar 12, 1998·International Journal of Cancer. Journal International Du Cancer·S VeroneseM Barbareschi
Aug 12, 1998·International Journal of Cancer. Journal International Du Cancer·G RoosG Landberg
Aug 12, 1998·International Journal of Cancer. Journal International Du Cancer·A AdeyinkaN Pandis
Feb 13, 1999·International Journal of Cancer. Journal International Du Cancer·J M GeeR I Nicholson
Jun 17, 1999·International Journal of Cancer. Journal International Du Cancer·F FarabegoliM Derenzini
Jun 17, 1999·International Journal of Cancer. Journal International Du Cancer·W J MerchantD M Barnes
Jul 15, 1999·International Journal of Cancer. Journal International Du Cancer·A AdeyinkaN Pandis
Mar 17, 2000·International Journal of Cancer. Journal International Du Cancer·A C LeongC E Gillett
Aug 14, 1998·Diagnostic Cytopathology·A Abati, G McKee
Jan 1, 1996·Seminars in Surgical Oncology·S Shousha
Feb 13, 2001·The Journal of Pathology·E C MommersP J van Diest
Jun 22, 2000·International Journal of Cancer. Journal International Du Cancer·D LiuS A Imam

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.